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Abstract
Background: Increasing robustness via improvement of resistance to pathogens is a major selection objective in livestock
breeding. As resistance traits are difficult or impossible to measure directly, potential indirect criteria are measures of
immune traits (ITs). Our underlying hypothesis is that levels of ITs with no focus on specific pathogens define an individual’s
immunocompetence and thus predict response to pathogens in general. Since variation in ITs depends on genetic,
environmental and probably epigenetic factors, our aim was to estimate the relative importance of genetics. In this report,
we present a large genetic survey of innate and adaptive ITs in pig families bred in the same environment.
Methodology/Principal Findings: Fifty four ITs were studied on 443 Large White pigs vaccinated against Mycoplasma
hyopneumoniae and analyzed by combining a principal component analysis (PCA) and genetic parameter estimation. ITs
include specific and non specific antibodies, seric inflammatory proteins, cell subsets by hemogram and flow cytometry, ex
vivo production of cytokines (IFNa, TNFa, IL6, IL8, IL12, IFNc, IL2, IL4, IL10), phagocytosis and lymphocyte proliferation. While
six ITs had heritabilities that were weak or not significantly different from zero, 18 and 30 ITs had moderate (0.1,h2#0.4) or
high (h2.0.4) heritability values, respectively. Phenotypic and genetic correlations between ITs were weak except for a few
traits that mostly include cell subsets. PCA revealed no cluster of innate or adaptive ITs.
Conclusions/Significance: Our results demonstrate that variation in many innate and adaptive ITs is genetically controlled
in swine, as already reported for a smaller number of traits by other laboratories. A limited redundancy of the traits was also
observed confirming the high degree of complementarity between innate and adaptive ITs. Our data provide a genetic
framework for choosing ITs to be included as selection criteria in multitrait selection programmes that aim to improve both
production and health traits.
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Introduction
Increasing robustness by improving resistance/tolerance to
pathogens is an important selection objective in most livestock
species, particularly in pigs. In the past 30 years, selection for
growth, carcass leanness, meat quality and prolificacy, combined
with stringent sanitary rules, vaccination and use of antibiotics, has
been highly effective in pigs [1]. Since the early 2000’s,
prophylactic use of antibiotics as growth promoters has been
forbidden by European legislation. As a result, the health status of
numerous farms has deteriorated, leading to an increase in the
therapeutic use of antibiotics. Indeed, animals highly selected for
production traits may be more susceptible to pathogens or less able
to maintain performance after infection. Deterioration of the
global health status may also be due to environmental trends. In
this context, including health traits in existing breeding schemes
using direct and/or indirect strategies is an emerging trend in pig
breeding. Direct strategies target animal resistance/tolerance to
specific pathogens but may result in increased susceptibility to
other diseases [2,3]. Alternatively, an indirect and putatively more
global approach focuses on immune traits (ITs) providing a
measure of immune capacity (i.e. immunocompetence) and
hopefully predicting the responses to pathogens in general [4].
The choice of relevant ITs is further based on knowledge of the
immune system. This highly interactive and cooperative system is
classically separated into two arms referred to as innate and
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the first line of defence. Its activation is non pathogen-specific and
depends on the recognition of evolutionarily conserved pathogen-
associated molecular patterns such as lipopolysaccharides consti-
tuting bacterial cell walls [5]. Innate immunity involves physical
barriers, innate immune cells such as dendritic cells (DCs),
monocytes, natural killers (NK cells) or cd T lymphocytes, and
inflammatory cytokines such as IL1B, IL6 and TNF. Adaptive
immunity is antigen-specific and requires the recognition of
specific ‘‘non-self’’ antigens via a process of antigen presentation
and results in an immunological memory. Adaptive immunity is
divided into cell- and humoral-mediated immunity with different
effector functions [6].
In order to include ITs in a breeding plan to improve pig
immunocompetence, the genetic and phenotypic parameters of
the different ITs need first to be estimated. Several studies in
swine, mice, poultry and cattle demonstrated the possibility of
selecting animals with high or low immune response (IR) as
characterized by one or a few ITs [2,7,8,9,10]. A study on
Yorkshire pigs selected for eight generations for high and low
adaptive IR (HIR and LIR, respectively) on an index combining
four standardized measures of specific antibodies and cell-
mediated IR, after stimulation with specific antigens (bacillus
Calmette-Gue ´rin and hen egg white lysozyme), has revealed that
HIR and LIR animals differ in response to immunization and
infection [2,11,12,13,14]. Other studies have also shown that
various innate and adaptive ITs are genetically controlled. For
example, variation in innate ITs, such as NK cells, monocytes,
interferon a (IFNa) production or phagocytosis [15,16,17] is
heritable and several adaptive ITs have moderate to high
heritability values including total white blood cells (WBC), CD4
+
T lymphocyte, CD8a
+ T lymphocyte and B lymphocyte subsets
[15,16,17], delayed-type hypersensitivity reaction [15,18], lym-
phocyte proliferative response [15], interleukin-2 (IL2) production
by lymphocytes [15] and antibody response [12,15,18,19].
Clapperton and colleagues have also reported that variation in
acute phase protein levels is heritable [16,17]. Finally, several
significant QTLs for total leukocyte count ([20,21]; Animal-
QTLdb, http://www.animalgenome.org/cgi-bin/QTLdb/index),
mitogen-induced proliferation [20], antibody response [20,22],
cytokine production (IL10 and IFNc) [23], complement activity
[22], and acute phase protein serum concentration [22] have been
detected and mapped to different pig chromosomes. Taken
together these data demonstrate that variation in some ITs is
under genetic control. However, most of the results reported so far
have targeted a limited number of traits and very few studies have
combined innate and adaptive ITs.
Our global goal is to identify immunocompetence traits for
inclusion in selection schemes aiming to improve both zootech-
nical performances and health traits in pigs. For this purpose, we
have launched a genetic and genomic study of numerous ITs
covering innate and adaptive IR [24]. In this report, we present
the results of a global genetic study, combining principal
component analysis (PCA), and genetic parameter estimation
applied to a large number of innate and adaptive ITs in a pig
population vaccinated against Mycoplasma hyopneumoniae (M.
hyopneumoniae).
Results
ITs and descriptive statistics
A set of 54 ITs was measured on a population of 443 pigs three
weeks after vaccination against M. hyopneumoniae (Tables 1 and 2;
Table S1; Figure 1). These ITs comprise either traits related to IR
(phagocytosis, lymphocyte proliferation, cytokine production after
in vitro stimulations, levels of total and specific antibodies, levels of
acute phase proteins) or traits related to total leukocyte and
leukocyte subpopulation counts. The various characteristics and
descriptive statistics of the traits measured on each animal of the
studied population (n=383 to 442) are summarized in Tables 1
and 2. Among the cell-mediated ITs evaluated after diverse
stimulations, higher responses in cytokine levels were observed
after phorbol myristate acetate (PMA)-Ionomycin (PMAIONO)
stimulation compared to lipopolysaccharide (LPS) and concanav-
alin A (CONA) stimulations, except for IL2 production.
Conversely, a higher lymphocyte proliferation was detected after
CONA and PMAIONO stimulations than after LPS stimulation.
Ample phenotypic variation was observed for most traits. The
coefficient of variation (CV) was equal to 0.8 on average and
ranged from 0.07 to 3.9 (Tables 1 and 2). Limited dispersion
(CV#0.9) was observed for traits derived from hemograms, cell
subsets characterized by fluorescence-activated cell sorting
(FACS), phagocytosis capacity and non-specific immunoglobulins.
Moderate dispersion (0.9,CV#1.5) was observed for most
cytokines produced in vitro except for tumour necrosis factor a
(TNFa) and mitogen proliferation-related traits. Finally, the CV
for seric C reactive protein (CRP) and haptoglobin (HAPT) levels
were close to 1.6 and 2, respectively. The highest CV (3.9) was
obtained for the specific IgGs directed against M. hyopneumoniae.
These data clearly indicate that the seric inflammatory protein
levels and the specific IgGs had the greatest phenotypic variance in
our study.
Multivariate dispersion and phenotypic correlations
In order to analyse the factors causing the variation, we
performed a normed PCA with 32 traits (Tables 1 and 2). For cell-
mediated adaptive IR, we included only those traits related to
cytokine production and lymphocyte proliferation after PMA-
ionomycin stimulation. For innate ITs, we included 10 FACS-
characterized cell subtypes including the percentages of B
lymphocytes (IgM
+), cd T lymphocytes (TCRcd
+), three subsets
of ab T lymphocytes (CD4
+ CD8
+, CD4
- CD8
+ and CD4
+ CD8
-),
NK cells (CD16
+ CD2
+) and three monocyte subsets (CD16
+
CD172A
+, CD16
+ MHCII
+, MHCII
+ CD172A
+). We excluded
from the analysis four haematological traits not directly involved in
immunity: red blood cell count (RBC), hematocrit (HT), red blood
cell distribution width (RDW) and platelet count (PLT). The
percentage of variance (inertia) explained by the first five
components was over 50% (Figure 2A). Each of these five
components explained more than 5% of the total variance and the
first two components accounted for 16.4 and 10.8% of the total
variance, respectively. Taking into account the 32 components
from PCA, multivariate normal mixture modelling and model-
based clustering (see Materials and Methods) were used to identify
clusters of ITs. The highest Bayesian Information Criterion (BIC)
was obtained using the diagonal model with variable shape and
variable variance (VVI in pink on Figure 2B) and K=3 (first
factorial plan on Figure 2C). No parameter was located near the
correlation circle indicating that the phenotypic correlations
between ITs are globally weak. A first cluster (K1 in blue on
Figure 2C) groups together four hemogram–derived cell counts:
white blood cell count (WBC), lymphocyte count (LYM),
monocyte count (MON) and neutrophil count (NEU). This cluster
is representative of total cell number traits despite the eosinophil
count (EOS) not being included. A second cluster (K2 in green on
Figure 2C) groups together all the traits related to FACS-
characterized leukocyte subpopulations (expressed as the percent-
age of cells with one or two surface antigens) except cd T
Genetic Control of Immunity
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+), with a cell response parameter (IL10-
PMAIONO) and the seric level of haptoglobin (HAPT). This
cluster can be considered as representative of the leukocyte
subsets. A third cluster (K3 in red on Figure 2C) includes all other
cell response traits, one hemogram-derived cell count (EOS) and
one FACS-characterized leukocyte subpopulation. Note that K1
and K2 related traits, which mainly correspond to cell subsets and
explain around 25% of the phenotypic variance, show clear
clustering (Figure 2C). These traits are grouped on the first PCA
axis and separated on the second axis. Traits belonging to K3,
representative of cell activity (cytokine production, phagocytosis
and antibody production), are more spread out on the other axes
(data not shown). Interestingly, cluster analysis did not highlight
any cluster of innate or adaptive ITs.
The estimation of phenotypic correlations (^ r rp) with WOMBAT
confirmed that the ITs are weakly correlated, except i) among a
few cell count traits (WBC, LYM, MON, NEU), and ii) between
cell count traits and a few leukocyte subsets (WBC, LYM, CD16
+
CD2
+ and CD4
- CD8
+) for which ^ r rp greater than 0.4 were
estimated (Table S2; Figure S1). Weak ^ r rp were mainly positive
(330) with 166 negative. No strongly negative ^ r rp (#20.4) were
found. Taken together, PCA and estimations of phenotypic
correlations showed that the level of redundancy between the
different immune parameters was limited.
A broad range of ITs is heritable
Heritability estimates of the 54 analyzed ITs was equal to 0.45
on average (se =0.20; Table 1 and 2). Thirty, 18 and six traits
were highly (h2
^
. 0.4), moderately (0.1,h2
^
#0.4) and weakly/not
(h2
^
# 0.1) heritable, respectively. Moreover, among the highly
heritable traits, 24 had a 95% confidence interval (95CI) of
heritability that did not overlap zero. The average estimated
heritability values of ITs measured directly on blood (h2 = 0.42, se
=0.19) or by in vitro tests (h2 = 0.50, se =0.22) did not significantly
differ. Overall, average estimated heritabilities were equal to 0.38
(se=0.19) for innate ITs, 0.40 (se =0.19) for humoral adaptive
ITs and 0.51 (se =0.22) for cellular adaptive ITs. For the large set
of adaptive ITs, the mean heritability was 0.48 (se =0.21). No
significant difference in average heritability values was detected
either between group of ITs qualifying the innate and adaptive
immunity or the humoral and cellular adaptive immunity. In
addition, an equivalent proportion of innate and adaptive ITs had
significant heritability values. Indeed, 40% (10/25), 40% (2/5) and
Table 1. Descriptive statistics and heritability estimates of the ITs contributing to global and adaptive immunity.
Type of traits Trait symbol N
& Mean sd CV h
2 (se) 95%CI of h
2 h
2 levels
#
Global immunity WBC
* 440 18.0 5.2 0.28 0.73 (0.20) [0.33–1.12] High
LYM
* 440 12.7 3.7 0.29 0.72 (0.21) [0.30–1.13] High
Cell-mediated
adaptive immunity
IL4-CONA 434 117.9 120.5 1.02 0.55 (0.20) [0.10 – 0.94] High
IL4-PMAIONO
* 438 1360.2 1804.7 1.32 0.61 (0.22) [0.10– 1.00] High
IL4-LPS 438 77.6 80.9 1.04 0.15 (0.18) [0 .00– 0.50] Moderate
IL10-CONA 438 305.0 404.4 1.32 0.50 (0.21) [0.00 – 0.91] High
IL10-PMAIONO
* 438 1444.7 1492.7 1.03 1.00 (0.21) [0.50 – 1.00] High
IL10-LPS 438 506.9 610.4 1.20 0.35 (0.19) [0.00 – 0.72] Moderate
IFNG-CONA 437 516.9 552.2 1.06 0.41 (0.19) [0.00 – 0.78] Moderate
IFNG-PMAIONO
* 437 56799 79326 1.39 0.52 (0.20) [0.10 – 0.91] High
IFNG-LPS 438 530.4 692.6 1.30 0.00 (0.17) [0.00 – 0.33] Weak
IL2-CONA 436 9827.3 8707.5 0.88 0.88 (0.55) [0.00 – 1.00] High
IL2-PMAIONO
* 438 7159.5 7257.6 1.01 0.71 (0.21) [0.2 – 1.00] High
IL2-LPS 438 6696.1 6152.6 0.91 0.91 (0.19) [0.50 – 1.00] High
CD4
- CD8
+ * 383 13.8 7.1 0.51 0.50 (0.23) [0.00 – 0.95] High
CD4
+ CD8
+ * 383 3.1 2.0 0.63 0.64 (0.22) [0.20 – 1.00] High
CD4
+ CD8
-* 431 5.1 3.0 0.57 0.54 (0.21) [0.10 – 0.95] High
PROLIF-CONA 392 28.1 33.9 1.20 0.36 (0.20) [0.00– 0.75] Moderate
PROLIF-PMA
* 392 30.5 48.3 1.57 0.27 (0.20) [0.00 – 0.66] Moderate
PROLIF-LPS 392 0.3 0.5 1.29 0.31(0.19) [0.00 – 0.68] Moderate
Humoral-mediated
adaptive immunity
IgM
+ * 384 22.1 12.3 0.55 0.00 (0.21) [0.00 – 0.41] Weak
IgG-Mh
* 441 0.3 1.2 3.90 0.12 (0.19) [0.00 – 0.49] Moderate
IgA
* 441 44.7 25.2 0.56 0.68 (0.20) [0.20 – 1.00] High
IgG
* 436 68.9 37.1 0.53 0.92 (0.21) [0.50 – 1.00] High
IgM
* 441 74.3 55.6 0.74 0.31 (0.18) [0.00–0.66] Moderate
&N = number of progeny measured for each IT.
*ITs taken into account in PCA and for which genetic correlations have been estimated.
#high (h
2.0.4), moderate (0.1,h
2,0.4), weak (h
2#0.1).
ITs with significant h
2 (95CI excluding 0) emboldened.
doi:10.1371/journal.pone.0022717.t001
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cellular-mediated adaptive ITs, respectively, had a 95CI of h
2
that did not overlap zero. Focussing on the three clusters identified
with PCA, the average heritability values of traits included in the
clusters K1, K2 and K3 reached 0.61 (se =0.20), 0.54 (se =0.20)
and 0.43 (se =0.20), respectively.
Among the traits involved in cell-mediated immunity, variation
in ab T lymphocyte (CD4
- CD8
+, CD4
+ CD8
+ and CD4
+ CD8
-
cells) counts was highly heritable. Heritability estimates of the
three cytokine (IL4, IL10, IFNG) levels were moderate to high
after PMAIONO and CONA stimulations and weak to moderate
after LPS stimulation. For those cytokines induced by CONA or
LPS stimulation, confidence interval (95CI) for the heritabilities
overlapped zero, except for IL4-CONA. IL2 production after
PMAIONO, CONA and LPS stimulations gave high estimates of
heritability significantly different from zero for IL2-PMAIONO
and IL2-LPS. Proliferation measurements after various stimula-
tions (PROLIF-CONA, PROLIF-PMAIONO, PROLIF-LPS)
provided moderate estimates of heritability not significantly
different from zero. Among the traits involved in humoral-
mediated adaptive immunity, heritabilities for total IgG and IgA
antibody levels were higher than for total IgM and specific
antibodies, and weak h2
^
values were obtained for B lymphocyte
count (IgM
+ cells).
Heritability for innate ITs such as i) total cell number (EOS and
NEU), ii) leukocyte subsets (CD16
+ CD2
+ cells, CD16
+ CD172A
-
cells, CD16
+ MHCII
+ cells and TCRcd
+ lymphocytes), iii)
cytokine production (IFNA and IL12), and iv) phagocytosis were
high and significantly different from zero. In addition, several
innate ITs showed weak to moderate heritability, including pro-
inflammatory cytokines (IL1B, IL8, TNF and IL6), MON, CD16
-
CD2
+ cells, CD16
+ CD2
- cells, MHCII
- CD172A
+ cells, MHCII
+
Table 2. Descriptive statistics and heritability estimates of the ITs contributing to innate immunity and of other hematological
traits.
Type of traits Trait symbol N
& Mean sd CV h
2 (se) 95%CI of h2 h
2 levels
#
Innate immunity MON
* 440 1.0 0.4 0.36 0.38 (0.20) [0.00 – 0.77] Moderate
NEU
* 440 3.9 1.8 0.45 0.61 (0.20) [0.20 – 1.00] High
EOS
* 440 0.2 0.1 0.40 0.80 (0.21) [0.30 – 1.00] High
IL1B
* 442 6150.7 5581.8 0.90 0.12 (0.19) [0.00– 0.49] Moderate
IL8
* 442 10663 12666 1.18 0.00 (0.17) [0.00 – 0.33] Weak
TNF
* 442 2091.6 1619.9 0.77 0.00 (0.19) [0.00 – 0.37] Weak
IL6
* 439 222.2 435.5 1.95 0.11 (0.19) [0.00 – 0.48] Moderate
IFNA
* 404 394.1 628.2 1.59 0.60 (0.23) [0.10 – 1.00] High
IL12
* 442 740.1 785.4 1.06 0.51 (0.20) [0.10 – 0.90] High
CD16
- CD2
+ 432 18.4 8.6 0.46 0.32 (0.21) [0.00 – 0.73] Moderate
CD16
+ CD2
+ * 432 8.5 5.6 0.65 0.81 (0.20) [0.40 – 1.00] High
CD16
+ CD2
- 432 16.6 11.2 0.67 0.05 (0.16) [0.00 – 0.36] Weak
MHCII
- CD172A
+ 384 12.6 9.1 0.71 0.25 (0.21) [0.00 – 0.66] Moderate
MHCII
+ CD172A
+ * 384 5.7 3.1 0.54 0.48 (0.21) [0.00 – 0.89] High
MHCII
+ CD172A
- 432 19.1 9.5 0.49 0.39 (0.20) [0.00 – 0.78] Moderate
CD16
- CD172A
+ 384 1.5 1.2 0.75 0.30 (0.22) [0.00 – 0.73] Moderate
CD16
+ CD172A
+ * 384 17.4 10.7 0.61 0.21 (0.20) [0.00 – 0.60] Moderate
CD16
+ CD172A
- 432 9.0 7.2 0.79 0.74 (0.20) [0.30 – 1.00] High
CD16
- MHCII
+ 432 15.4 7.2 0.46 0.02 (0.17) [0.00 – 0.35] Weak
CD16
+ MHCII
+ * 431 9.6 5.8 0.60 0.71 (0.19) [0.30 – 1.00] High
CD16
+ MHCII
- 432 14.8 9.7 0.65 0.17 (0.20) [0.00 – 0.56] Moderate
TCRcd
+ * 431 12.4 7.9 0.63 0.69 (0.21) [0.20– 1.00] High
PHAG
* 414 33.7 10.2 0.30 0.62 (0.22) [0.10 – 1.00] High
HAPT
* 440 0.7 1.6 2.05 0.55 (0.21) [0.10 – 0.96] High
CRPT
* 440 106.5 167.1 1.56 0.18 (0.18) [0.00 – 0.53] Moderate
Other
hematological
traits
RBC 440 6.2 0.5 0.07 0.43 (0.20) [0.00 – 0.82] High
HT 440 30.8 4.8 0.15 0.57 (0.03) [0.50 – 0.62] High
RDW 440 14.8 1.5 0.10 0.70 (nd) nd High
PLT 440 539.3 257.2 0.47 0.56 (0.19) [0.10 – 0.93] High
&N = number of progeny measured for each IT.
*ITs taken into account in PCA and for which genetic correlations have been estimated.
#high (h
2.0.4), moderate (0.1,h
2,0.4), weak (h
2#0.1).
ITs with significant h
2 (95CI excluding 0) emboldened.
doi:10.1371/journal.pone.0022717.t002
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- cells, CD16
- CD172A
+ cells and CD16
+ CD172A
+ cells.
Variation in acute phase proteins was moderately (CRP) to highly
(HAPT) heritable. Among the four traits, which measured the total
number (MON) or proportions (MHCII
+ CD172A
+, CD16
+
CD172A
+ and CD16
+ MHCII
+) of monocytes, moderate to high
h2
^
, but not significantly different from zero, were estimated, except
for CD16
+ MHCII
+ cells. Other haematological traits (RBC, HT,
RDW and PLT) gave high h
2 estimates, of which HT and PLT
were significant.
Genetic correlations among ITs
Pairwise genetic correlations are presented in Table S2 and
illustrated in Figure 3. Genetic correlation estimates among most
ITs were generally weak but a few high genetic correlations were
observed. The number of positive genetic correlations (310) was
higher than that of negative correlations (183), as already observed
for phenotypic correlations. Positive genetic correlations were
higher (in absolute values) than negative ones (Table S2, Figures 3
and S1). Only 28 (2.7% of the total number of correlations) and
five rg
^
(0.4% of the total number of correlation estimates) were
higher than 0.4 or lower than -0.4, respectively.
The unsupervised hierarchical clustering distinguished two
main clusters of traits (Figure 3). The first cluster of 14 traits
(Cluster A) could be divided into two groups: i) a group of four
traits including one innate immunity cytokine (IFNA), two
antibody levels (total IgG and specific IgG-Mh), and one FACS-
characterized leukocyte subpopulation (CD16
+ CD172A
-) and ii) a
group of 10 traits with nine hemogram-based cell counts or FACS-
characterized leukocyte subpopulations (WBC, LYM, MON,
NEU, EOS, CD16
+ MHCII
+, CD16
+ CD2
+, CD4
- CD8
+ cells)
and two cell activity traits (IgM and IL10-PMAIONO). The
second cluster of 18 traits (Cluster B) is also subdivided into two
groups of traits: i) a group of three different cell response traits
(IL6, IgA and IFNG-PMAIONO) and one FACS-characterized
leukocyte subpopulation (IgM
+ cells), and ii) a group of nine cell
response traits (IL12, IL4-PMAIONO, IL2-PMAIONO, TNF,
PROLIF-PMA, HAPT, CRP, IL1B, IL8 and PHAG) and four
FACS-characterized leukocyte subpopulations (CD4
+ CD8
-,
CD4
+ CD8
-, TCRcd
+ and MHCII
+ CD172A
+ cells). In cluster
A, the first group of 10 traits showed moderately to highly positive
genetic correlations with each other. Indeed, rg
^
values greater than
0.4 were estimated between WBC, LYM, MON, NEU, EOS,
CD4
- CD8
+ and CD16
+ CD2
+ (NK) cells (Figure 3, Table S2). In
cluster B, rg
^
values greater than 0.4 were estimated between i) TNF,
IL8 and PHAG, and ii) CRP and HAPT (Figure 3, Table S2).
Strong negative rg
^
values (,20.4) were found between a few traits
from both clusters: i) TNF and three cell number traits (WBC,
LYM, MON), ii) IL6 and CD16
+ MHCII
+, and iii) CRP and IgA.
Discussion
The measured ITs globally cover innate and adaptive
immunity
The large-scale study reported here allowed us to estimate the
genetic and phenotypic parameters of numerous ITs measured on
pigs bred in the same environment. Innate immunity is
represented by 25 traits, humoral-mediated immunity by five
traits and cell-mediated adaptive immunity by 18 traits. We have
also considered the total number of white blood cells and
lymphocytes, and four other haematological traits (RBC, HT,
RDW and PLT). Within cell-mediated immunity, we explored
both Th1 and Th2 responses by measuring cytokine production.
Figure 1. Position of the measured ITs on a global scheme of immunity. The global scheme of immunity was obtained using Ingenuity
Pathway Analysis software v 8.8 (Ingenuity Systems Inc., USA, http://www.ingenuity.com/). Cellular subsets and membrane proteins considered in this
study are in yellow and cell activity traits in green. For each trait, the heritability estimate rounded to one decimal place is shown in red.
doi:10.1371/journal.pone.0022717.g001
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globally. These traits include in vivo measures on blood such as
quantification of cell populations by hemogram, dosage of
circulating immunoglobulins and acute phase proteins, as well as
ex vivo measures obtained after in vitro tests such as lymphocyte
proliferation, phagocytosis capacity and cytokine production after
blood stimulation. All these ITs have been widely studied in
humans [25,26]. The trait typology we have used (Table 1) follows
a model based on a clear distinction between innate and adaptive
immunity, which may be over-simplistic since both immune
systems are closely interconnected [27,28]. Monocytes are
involved in innate immunity but are also antigen-presenting cells
required for adaptive immunity, and cytokines such as IL12 are at
the interface between innate and adaptive immunity. Similarly, the
cell-mediated and humoral adaptive immunity subdivision is
artificial. For example, IL4 is a cytokine produced by Th2
lymphocytes that is usually classified as part of adaptive cell-
mediated immunity, whereas it is also involved in antibody
production and thus adaptive humoral immunity. In addition, the
conventional paradigm that CD4
+ ab T lymphocytes differentiate
into Th1 and Th2 lineages expressing specific cytokines is
collapsing. Indeed, recent studies have revealed that cytokine
production by the different CD4
+ T cell subsets (Th1, Th2, Th,
Th17 and iTreg) is highly flexible, providing new insight into the
Th cell plasticity [29]. Nevertheless, although schematic, the
approach used in our report provides a comprehensive overview of
genetic variation and co-variation across the entire immune
spectrum in pigs (Figure 1).
Phenotypic variation of ITs
Table 1 illustrates various ranges of phenotypic variation in the
measured immune traits, with most having a CV over 0.5. Such
variability has already been reported in large panels of healthy
humans [26], and in previous studies on pigs [2,16,17,30]. For
instance, we substantiated the high level of variation of cytokine
production previously reported for IL2 production and virus-
induced IFNa production in a Swedish Yorkshire population [20].
For innate immunity-related cytokines and IL12, stimulation was
performed with a mixture of LPS, PMA and ionomycin. IL8 was
the cytokine produced with the highest levels followed by IL1B,
TNF, IL12 and lastly IL6. These four cytokines are not expected
to be expressed at similar levels at all time points after stimulation
and a kinetic study would help to improve comparison of cytokine
production levels. Weaker levels of adaptive IR cytokines are
observed after LPS stimulation compared to CONA or
PMAIONO. These differences could be related to the distinct
modes of action of these molecules. Indeed, PMA, a plant-derived
functional analog of diacylglycerol, in conjunction with ionomycin,
a calcium ionophore produced by Streptomyces conglobatus, and
CONA, a lectin originally extracted from the jack-bean Canavalia
ensiformis, are known to be potent mitogens of blood lymphocytes
[31,32]. LPS, a major structural component of the outer
membrane of gram-negative bacteria, which binds the CD14/
Figure 2. Normed PCA on 32 ITs. A. Histogram of eigenvalues. The
five first components, which explain more than 50% of the total
variance, are in red. B. Plot of the Bayesian Information Criterion (BIC)
calculated with different models according to number of clusters. Six
models are compared: EII (spherical with equal volume and equal
shape), VII (spherical with variable volume and equal shape), EEI
(diagonal with equal shape and equal volume), VEI (diagonal with
variable shape and equal volume), EVI (diagonal with equal shape and
variable volume), VVI (diagonal with variable shape and variable
volume). C. First factorial plan (1: first component, 2: second
component) with three clusters identified by multivariate normal
mixture modelling and model-based clustering taking into account the
32 components (clusters K1, K2 and K3 are in blue, green and red,
respectively).
doi:10.1371/journal.pone.0022717.g002
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inflammatory cytokines, has been extensively used to study innate
immune response [33]. We have already shown that transcriptome
modifications in peripheral blood mononuclear cells (PBMCs)
differ between PMAIONO and LPS stimulation and that
PMAIONO and LPS target different cells and cellular pathways
[34]. The combination of PMA and ionomycin induces a stronger
stimulation that may be related to a higher production of cytokines
as detected in the present study. In addition, the lymphocyte
proliferation induced by LPS is weaker than that observed with
other stimulants, as expected.
Variation in numerous ITs is genetically controlled
Our study provides the first heritability estimates for innate and
adaptive cytokine production and for lymphocyte proliferation after
PMA-ionomycin and LPS stimulations in pig. Pro-inflammatory
cytokines appear to show less heritable variation than adaptive
system-related cytokines. Among the adaptive system-related
cytokines, estimated heritability was weakest for cytokines produced
after LPS stimulation, except for IL2 production. Heritability
estimates for lymphocyte proliferation after CONA, PMA and LPS
stimulations were moderate and that of lymphocyte proliferation
after CONA stimulation was comparable to the value obtained by
Edfors-Lilja and colleagues [15]. Moderate to high heritability
estimates for cell count traits from hemogram or FACS also
confirmed those previously obtained for WBC, total lymphocytes,
neutrophils, eosinophils and some leukocyte subsets (for CD4
+ and
CD8
+ T lymphocytes, cd T lymphocytes, CD11R1
+, CD11R1
+
CD8a
-, CD11R1
+ CD8a
+ and CD16
+ MHCII
+) [15,16,17,19].
Likewise, our results confirmed the high heritability estimate for
phagocytosis [15]. Conversly, a lower heritability estimate for CRP
than previously reported was observed [15,16]. Overall, the
heritability estimates for these traits appear robust regardless of
populations, environments and protocols.
Some discrepancies exist between our heritability estimates and
previous results for humoral-mediated adaptive ITs and some
innate ITs. Indeed, in our study, B lymphocyte levels (IgM
+ cells)
are not significantly heritable contrary to other results [16,17] and
specific IgGs (IgG-Mh) have lower heritability estimates (0.12, se
=0.19) than previously reported (range from 0.27 to 0.45) for
specific antibodies directed against other antigens [12]. Our
estimated heritability for total IgG is higher (0.92, se =0.20) than
in published reports [3,15,18,19]. In addition, our estimated h
2 for
IFNa production is moderate to high (0.60, se =0.23), contrary to
previous results (range from 0 to 0.08) [15], and for haptoglobin
(0.55, se =0.21) is higher than previously published (range from
0.14 to 0.23) [17,19]. These discrepancies could be due to
differences in the pig breeds and in environment factors but also to
Figure 3. Heatmap of the genetic correlations between 32 ITs. The correspondence between colour scale and genetic correlation levels are
presented on the right-hand side of the heatmap.
doi:10.1371/journal.pone.0022717.g003
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tories. In order to better qualify the phenotypes, protocol
standardisation is needed.
Overall, we show that variation in both innate and adaptive ITs
is under substantial genetic control (Figure 1; Tables 1 and 2).
Similar heritability estimates for innate and adaptive ITs and also
between cell number and cell response parameters were observed.
Further, heritability estimates do not differ consistently between in
vivo and ex vivo measures with no apparent bias due to phenotyping
methods. These data also suggest candidate ITs for QTL
mapping. Indeed, mapping studies have already started for total
leukocyte count ([20,21]; AnimalQTLdb, http://www.animal-
genome.org/cgi-bin/QTLdb/index), mitogen-induced prolifera-
tion [20], antibody response [20,22], cytokine production (IL2,
IL10 and IFNc) [23,35], complement activity [22], and acute
phase protein serum concentration [22].
Phenotypic and genetic correlations illustrate the
complementarity of the different ITs
Compared to the previously limited data on genetic correlations
between ITs in pigs, our study provides a large-scale estimation of
phenotypic and genetic correlations among 32 ITs. PCA results and
correlation estimations highlight the weak phenotypic and genetic
correlationsbetweenthe differentITs,exceptmainlyforcellsubsets.
No cluster of innate and adaptive ITs is revealed. These results
illustratethat many oftheITsincluded inourstudy provide more or
less independent potential clues for selecting for improved
immunocompetence. Such complementarity is expected since
innate immunity is in place or ready for activation prior to infection
or antigenic stimulation and collaborates with adaptive immunity,
which is induced by infection or antigenic stimulation. Nevertheless,
a few highly positive genetic correlations have been detected
between total number of white blood cells and some leukocytes
subsets, andbetweensomeleukocytesubsets such astotal numberof
lymphocytes, CD4
- CD8
+ lymphocytes (which contains ab CD4
-
CD8
+ lymphocytes and NK), and NK cells (CD16
+ CD2
+ cells).
Phagocytosis, production of IL8 and TNF, two pro-inflammatory
cytokines produced bymonocytesandmacrophages,werepositively
correlated with acute inflammatory phase proteins produced by
hepatocytes i.e. CRP and HAPT. A high correlation was also found
between CRP and HAPT. Clapperton and colleagues [17] have
shown that phenotypic correlations between leukocyte subsets and
acute phase proteins are weak (,0.2) and not significantly different
from zero in agreement with our results. In contrast to our study,
Clapperton and collaborators have not detected any significant
genetic and phenotypic correlations between different leukocyte
subsets except when one subset was nested in another [16].
Toward the introduction of ITs in pig selection designs
Our results provide a framework for including ITs in multitrait
selectionforimmunocompetenceinpigs.Criteriaforinclusionshould
take into account heritability, biological relevance, biological
sensitivity and feasibility of measurement [25]. The weak genetic
correlations between most ITs suggestthat it will be difficult to choose
only a few ITs to select for immunocompetence, and that a
combination of many traits may be required [26]. The moderate to
high heritabilities estimated for many traits together with the selection
study on pigs carried out by Wilkie and colleagues a decade ago
support the feasibility of selecting for immunocompetence [2,13].
Chickens have also been successfully divergently selected for carbon
clearance (phagocytic activity), high antibody response to Newcastle
disease virus three weeks after vaccination (adaptive humoral IR) and
wing web response to PHA (high cell-mediated immune response) for
more than twelve generations [9,36].
In order to include immunocompetence in selection for improved
health, a major challenge will be to correlate variation in heritable
ITs in healthy animals with inter-individual variability in response
to various pathogens. Testing this hypothesis will be a key point for
further use of ITs as indirect selection criteria in multitrait selection
to improve resistance to disease. Some results on genetic and
phenotypic relationships between immunocompetence and suscep-
tibility to specific pathogens have already been reported in the
literatureforpigs.Amongpigsselected foreightgenerationsforhigh
(HIR) or low (LIR) response based on an index of four cell and
humoral-mediated immunity traits, an increased specific antibody
response and lower polyserositis were observed in the HIR pigs
compared to the LIR pigs after challenge with a novel pathogen,
Mycoplasma hyorhinis [12,37]. Thus, animals with a high IR level to
unrelated challenges, as defined by Wilkie and colleagues [12,37],
have a better response to infection with Mycoplasma hyorhinis.
However, HIR pigs develop more severe arthritis than LIR pigs.
Indeed, the levels of humoral and cell-mediated adaptive ITs
included in the Wilkie et al index induce the formation of immune
complexes and/or the development of inflammatory responses,
central to the pathogenesis of Mycoplasma hyorhinis-induced arthritis.
Other correlation tests between ITs and response to various
infections are needed. However, it is important to remain cautious
with high responder animals, which could develop autoimmune
pathologies or pathological iummne responses.
All the studies on immunocompetence and resistance to disease
will have to be completed by estimation of genetic correlations
with economically important traits already under selection.
Negative genetic correlations have been reported between some
ITs (monocytes, CD11R1
+ cells) and average daily gain [16].
However a larger correlation study considering a higher number
of ITs and pig performances is needed and is ongoing in our
population. In the future, a more sustainable production system
may require a compromise with a slight decrease in performance
traded off for a gain in animal robustness. More studies are
required to better understand the correlations between ITs and
production traits and it is not established which levels of ITs would
be good predictors for resistance to pathogens if any. In
conclusion, our results show that variation in many ITs is under
significant genetic control in pigs and these findings may provide
insights in other species. Moreover, based on heritability and
correlation estimations, some of the ITs that we have studied
might be incorporated into selection schemes, provided they are
associated with improved global health and do not exhibit strong
antagonisms with other economically important traits.
Materials and Methods
Ethics Statement
Our experiment was conducted in accordance with the French
national regulations for humane care and use of animals in
research. No ethics approval was required for the vaccination and
the collection of blood samples under the then current regulations.
Experiments were performed under the individual license numbers
77-01 assigned to Marcel Bouffaud who was responsible for
experiments in the test farm, and 78-16 assigned to a veterinarian,
Dr Silvia Vincent-Naulleau. The experimentation agreement
number for the test farm at le Rheu was A35-240-7.
Animals and blood sampling
A total of 443 Large White pigs (castrated males, dam line)
tested for performance traits in a pig test station (UE450, INRA,
Le Rheu, France) was included in the study. The pigs were
distributed in seven contemporary groups and belonged to 307
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(+/2 1.7) piglets per boar. Animals were born and weaned in 16
different selection herds and arrived in the test station at five weeks
of age with no prior vaccination. They were placed into pens of 30
piglets in a post weaning unit and vaccinated against M.
hyopneumoniae (Stellamune, Pfizer, one injection) one day after their
arrival in the test station, when 36.3 days old in average. All pigs
were apparently healthy with no clinical sign of infection. All
animals were sampled three weeks after vaccination. Blood
samples were collected via the external jugular vein into tubes
with or without anti-coagulants, according to further use.
Serum and plasma collection
Blood collected in 10 mL tubes with no anti-coagulant was
centrifuged at 3200 g for 15 min at 4uC. The serum was collected
and stored at 220uC until use. Plasma was collected from blood
sampled in heparinised tubes and stored at 220uC before use.
Hemogram
Hemograms were measured with an MS4-5 counter (Eli-
techGroup, France) with blood sampled in EDTA tubes. Among
a set of 18 traits, nine were included in the genetic analyses: total
number of leukocytes, lymphocytes, monocytes, neutrophils,
eosinophils, erythrocytes, platelets and hematocrit (Tables 1 and 2).
Total and specific immunoglobulins
Total concentrations of immunoglobulin subsets were measured
by ELISA as previously described [38]. Plasma samples were
diluted 1:6000, 1:4000 and 1:60,000 to detect IgM, IgA and IgG,
respectively, in Tris–buffered saline and added to plates coated
with immunoglobulin class specific pig antibody (Bethyl laborato-
ries Inc., Interchim, France). The different subsets were detected
with the appropriate peroxidase anti-pig IgM, IgA or IgG (Bethyl
laboratories Inc.) and were quantified by reference to standard
curves constructed with known amounts of pig immunoglobulin
subsets. Anti-M. hyopneumoniae IgG titers were also measured by
ELISA using a commercial kit (ELISA ID ScreenH M. hyopneumo-
niae Indirect, IDVET, France). Absorbance was read at 450 nm
using an ELISA plate reader (Spectra thermo, Tecan, NC, USA)
and the Biolise 2.0 data management software.
Haptoglobin and C reactive protein
Haptoglobin and C reactive protein levels were measured in pig
serum by colorimetric tests (Phase Haptoglobin Assay, ABCYS
Biologie, France) and ELISA assays (Porcine C reactive Protein
Assay, ABCYS Biologie, France), respectively. Absorbance was
read at 450 nm using an ELISA plate reader (MRX revelation,
Dynex).
PBMC purification
PBMCs were purified by density gradient centrifugation. A
volume of 13 mL heparinised blood was added to Leucosept tubes
(Greiner Bio-one, France) pre-filled with 17 mL Ficoll (Lympho-
cytes Separation Medium, Eurobio, France) and centrifuged at
1200 rpm for 35 min. PBMCs were collected at the ficoll interface
and washed in 50 mL D-PBS without MgCl2 and CaCl2 (GIBCO,
Invitrogen, France). Cells were then incubated in 2 mL BD
Pharmlyse 1X (BD Biosciences, France) at room temperature.
Leukocyte sup-populations by flow cytometry
Purified PBMCs were washed in 50 mL D-PBS without MgCl2
and CaCl2, incubated with 2 mL pig serum at 4uC for 20 min,
washed again in 50 mL D-PBS without MgCl2 and CaCl2 and
then washed in 50 mL S/W buffer (1 g/L NaN3, 10 g/L bovine
serum albumin in PBS, pH 7.3) at a final concentration of 5.10
6
cells/mL. 10
6 cells were used for each antibody labelling. Single,
double or triple staining was performed using monoclonal
antibodies (mAbs) directed against i) CD2 (MSA4, isotype IgG2a,
VMRD) and CD16 (MCA1971, isotype IgG1, Serotec), ii) CD4
(PT90A, isotype IgG2a, VMRD) and CD8a (PT81B, isotype
IgG2b, VMRD) iii) TCRcd (MAC320, isotype IgG2a, BD
Biosciences Pharmingen), iv) IgM (PIG45A, isotype IgG2b,
VMRD) and v) MHCII (MSA3, isotype IgG2a, VMRD), CD16
(MCA1971, isotype IgG1, Serotec) and CD172a (74-22-15A,
isotype IgG2b, BD Biosciences Pharmingen). Briefly, PBMCs were
stained with primary mAbs for 25 min at 4uC, washed in S/W
buffer and stained with allophycocyanin-conjugated anti-mouse
IgG1 (BD Biosciences, France), phycoerythrin-conjugated anti-
mouse IgG2a (Southern Biotech, France), FITC-conjugated anti-
mouse IgG2b (Southern Biotech, France), APC-conjugated anti-
mouse IgG1 (BD Biosciences, France), phycoerythrin-conjugated
anti-rat IgG2a (BD Pharmingen, France), or phycoerythrin-
conjugated anti-mouse IgG2b (Southern Biotech, France). After
washing in S/W buffer, cells were fixed in BD Cellfix solution
(Becton Dickinson, Germany). Data acquisition and analysis were
carried out with the FACScan and CELLQuest software (Becton
Dickinson, UK).
Assay of leukocyte-derived IFNa after in vitro viral
stimulation of total blood
Synthesis of IFNa by leukocytes of pigs was tested in vitro by
incubating diluted total blood in the presence of pseudorabies virus
(PrV, Suid Herpesvirus 1)-infected, glutaraldehyde-fixed, PK15 cell
monolayers, according to a protocol previously described for
transmissible gastroenteritis virus [39]. Confluent PK15 cell
monolayers grown in 24 well plates were infected by PrV at a
multiplicity of infection of 20, fixed with 0.05% glutaraldehyde 8 h
post-infection and washed with D-PBS and RPMI1640 before the
addition of blood samples. For each animal, monolayers were
incubated with diluted heparinized blood (270 ml of blood diluted
1:5 in DMEM supplemented with antibiotics) for 18 h at 37uC.
Plates were then centrifuged at 450 x g for 20 min at 4uC, and
supernatants were collected and stored at -20uC. IFNa was
assayed in the supernatants using a classical sandwich ELISA test
as previously described [40].
Production and dosage of IL1B, IL6, IL8, TNFa and IL12
Heparinized blood samples (400 mL) were fivefold diluted in 24-
well plates in 1.6 mL RPMI 1640 medium (BioWhittaker,
Belgium) supplemented with 10% heat-inactivated fetal bovine
serum (QB perbio, UK), 2 mmol/L L-glutamine, 100 U/mL
penicillin and 100 mg/mL streptomycin. For stimulation, a
mixture of 10 ng/mL PMA (Sigma, France), 1 mg/mL ionomycin
(Sigma, France) and 1 mg/mL LPS from Escherichia coli O111:B4
(Sigma, France) was added to the diluted blood. For mock
stimulation, a volume of PBS equal to the volume of stimulation
reagents was added to the diluted blood. After incubation at 37uC
for 24 h, culture supernatants were collected by centrifugation at
450 g for 20 min and stored at 220uC before use.
The cytokines IL1B, IL6, IL8, TNF and IL12 were quantified
using commercial ELISA tests (DuoSet ELISA development kits,
R&D Systems, USA). For quantification of basal levels of cytokines
in supernatants from mock-stimulated cells, the samples were not
diluted for quantification. Supernatants collected from stimulated
cells were diluted (1:22 for IL1B and IL8, 1:1 for IL6, 1:10 for
TNF and 1:2 for IL12). All samples were tested in duplicates.
Absorbance was read at 450 nm using an ELISA plate reader
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cytokine/mL.
Production and dosage of IL2, IL4, IL10 and IFNc
Heparinized blood diluted 1:5 in complete culture medium
consisting of DMEM (Dulbecco’s Modified Eagle Medium,
Eurobio, France) supplemented with 5% fetal calf serum (Hyclone,
Perbio, France), 2 mM L-glutamine, 100 U/mL penicillin and
50 mg/mL streptomycin (Eurobio, France) was stimulated with
10 mg/mL CONA (Sigma, France), or with 50 ng/mL of PMA
(Sigma, France) and 1 mg/mL of ionomycin (Sigma, France) or
1 mg/mL LPS from Escherichia coli (Sigma, France). Cytokine
content was measured in supernatants using ELISA tests as
already described [41]. Briefly, purified fractions of anti-swine IL-
2, IL-4, IFNc (clones A150D 3F1, A155B 16F2 and A151D 5B8
respectively, Biosource, France) and IL10 (clone 148801, R and D
System, France) were used as capture antibodies, in conjunction
with the biotinylated anti-swine IL-2, IL-4, IL10 and IFNc
monoclonal antibodies (clones A150D 8H10, A155B 15C6 and
A151D 13C5, respectively, Biosource, Clinisciences, France) or
anti-swine polyclonal antibody (goat anti-porcine IL-10, R and D
System, France). Streptavidin-horseradish peroxidase (Biosource)
and TMB (Fermentas, MD, USA) were used for detection.
Absorbance was read at 450 nm using an ELISA plate reader
(Spectra thermo, Tecan, NC, USA) and the Biolise 2.0 data
management software. Recombinant pig IL-2, IL-4, IL10 and
IFNc were used as standards. The detection limits were 700 pg/
mL, 60 pg/mL, 90 pg/mL and 100 pg/mL for IL-2, IL-4, IL10
and IFNc, respectively. Results were expressed as pg of cytokine/
mL.
Measurements of lymphocyte proliferation
Lymphocyte proliferation was performed in 96 well plates as
already described [42]. Briefly, heparinized blood samples were
diluted 1:15 in complete culture medium consisting of DMEM
(Dulbecco’s Modified Eagle Medium, Eurobio, France) supple-
mented with 5% fetal calf serum (Hyclone, Perbio, France),
2 mM L-glutamine, 100 U/mL penicillin and 50 mg/mL strep-
tomycin (Eurobio, France). For detection of unspecific lympho-
cyte proliferation, the diluted blood samples were seeded in 96
well plates (200 mL/well) and mock-stimulated for 48 h by
incubation in culture medium (control wells), or stimulated for
48 h by incubation with the culture medium supplemented with
either 10 mg/mL ConA (Sigma, France), or 50 ng/mL of PMA
(Sigma, France) and 1 mg/mL of ionomycin (Sigma, France), or
1 mg/ml LPS (Sigma, France). Control wells remained unstimu-
lated. After 48 h of incubation at 39uC, 0.5 mCi of
3H-methyl-
thymidine (ICN, France) was added to each well. After another
24 h incubation period, the cells were harvested through glass-
fiber filters (Whatman, United Kingdom) by means of an
automatic harvester (Titerteck-Skatron, Molecular Devices,
France). Incorporation of tritiated thymidine was measured with
a Liquid Scintillation Beta Counter (Kontron Instruments,
France). Results were expressed as a stimulation index of
lymphocyte proliferation calculated as mean counts per min
(cpm) of the triplicate cultures in stimulated culture/mean cpm in
control non-stimulated culture.
Data analysis
Preliminary statistical analyses were performed using R software
[43]. In order to test if trait distributions deviated from Gaussian, a
D’Agostino normality test was used (p=0.05). Since most traits
were not sampled from a Gaussian distribution, they were all
normalized using a Box-Cox transformation except for phenotypes
reaching the value zero, which were normalized using ln(1+x)
transformation. Significant effects of age at the time of vaccination,
of time of vaccination, of breeding unit and of time of experiment
were detected for most traits by variance analysis taking into
account these effects. Normed Principal Component Analysis
(PCA, [44], dudi.pca function, ade4 package [45], R software [43])
on a subset of ITs adjusted for age at the time of vaccination, time
of vaccination, breeding unit and experiment (Table 1) were
performed using a linear model. Clusters of ITs were detected
using the R package mclust for normal mixture modelling and
model-based clustering [46]. It combines model-based agglomer-
ative hierarchical classification, based on the classification
likelihood, and the expectation-maximization (E–M) algorithm
for maximum likelihood estimation of multivariate mixture
models. Variance components, genetic parameters and their
standard errors were estimated by the Restricted Maximum
Likelihood (REML) method [48], using the WOMBAT software
[49]. This is the reference method to estimate genetic parameters
with a mixed model. Univariate and bivariate mixed linear animal
models were employed to estimate heritability and genetic
correlations, respectively. For the univariate analyses, the fixed
part of the model included experiment time, age at the time of
vaccination, vaccination time and herd of origin effects and the
random part included a common litter environmental effect and
direct genetic effects. In matrix notation
y~XbzWaazWccze
where y = the vector of observations; Xb,W a and Wc are known
incidence matrix relating observations to fixed and random effects;
ß = a vector of fixed effects and covariates; a = the vector of
direct genetic effects; c = the vector of common litter
environmental effects; and e = the vector of random residual
effects. All random effects were assumed to follow a normal
distribution with zero mean. For bivariate analyses, the same
effects as for univariate analyses were taken into account in the
fixed part of the model and a direct genetic effect was included in
the random part of the model. 95% confidence intervals (95CI)
were calculated for heritability (h
2) estimates (h2
^
). Heritability
estimates have been classified: high (h2
^
.0.4), moderate
(0.1,h2
^
,0.4) or weak (h2
^
#0.1). A graphical representation of
the genetic correlations combined with a hierarchical clustering
(euclidian distance, average link) was obtained with the heatmap
function from the Bioconductor software [50]. Comparisons of
heritability average between subsets of traits were tested using the
Wilcoxon Mann-Whitney Test (significance threshold p-val-
ue=0.05).
Supporting Information
Figure S1 Heatmap of the phenotypic correlations
between 32 ITs. The correspondence between colour scale
and genetic correlation levels are presented on the right-hand side
of the heatmap.
(TIF)
Table S1 Additional details on the measurements of the
ITs.
(XLS)
Table S2 Phenotypic and genetic correlations between
32 ITs.
(XLS)
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